Shou Chan

Shouchan Biotechnology is a Shanghai-based biotechnology company specializing in the development of next-generation cell therapies derived from induced pluripotent stem cells (iPSCs). The company focuses on treating degenerative diseases, with a primary emphasis on neurological disorders such as Parkinson's disease. By leveraging its proprietary iPSC differentiation platform, Shouchan aims to produce high-purity, functional cell products for regenerative medicine. The company's lead program involves the transplantation of iPSC-derived dopaminergic neurons to restore motor function in patients. Shouchan has attracted significant investment from prominent venture capital firms to advance its pipeline toward clinical trials.